Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
Showing 1,901 - 1,920 results of 14,257 for search '(( significant increase decrease ) OR ( significant ((greatest decrease) OR (mean decrease)) ))', query time: 0.49s Refine Results
  1. 1901
    Comparison of body weight gain between control group and cigarette smoke exposed group mice.

    Comparison of body weight gain between control group and cigarette smoke exposed group mice. by Yue He (385239)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 1902
    Role of MIB2 and CAMK2 in FAT1-depndent regulation of YAP/TAZ protein levels and YAP/TAZ nuclear localization.

    Role of MIB2 and CAMK2 in FAT1-depndent regulation of YAP/TAZ protein levels and YAP/TAZ nuclear localization. by Rui Li (4631)

    Published 2025
    Save to List
    Saved in:
  3. 1903
    Regulation of YAP/TAZ through MIB2 in HNSCCs.

    Regulation of YAP/TAZ through MIB2 in HNSCCs. by Rui Li (4631)

    Published 2025
    Save to List
    Saved in:
  4. 1904
    Incorporation of <sup>14</sup>C-palmitate and <sup>14</sup>C-acetate into triacylglycerol in <i>M</i>. <i>abscessus</i> is increased by NMP.

    Incorporation of <sup>14</sup>C-palmitate and <sup>14</sup>C-acetate into triacylglycerol in <i>M</i>. <i>abscessus</i> is increased by NMP. by Timilehin Faboro (20175963)

    Published 2024
    Save to List
    Saved in:
  5. 1905
    Role of YAP/TAZ in FAT1-regulated HNSCC growth.

    Role of YAP/TAZ in FAT1-regulated HNSCC growth. by Rui Li (4631)

    Published 2025
    Save to List
    Saved in:
  6. 1906
    Parameters for the treadmill during the acclimatization period.

    Parameters for the treadmill during the acclimatization period. by Wenbin Wu (292223)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1907
    KEGG pathway enrichment analysis of lactoferrin and Coenzyme Q10 in sarcopenia.

    KEGG pathway enrichment analysis of lactoferrin and Coenzyme Q10 in sarcopenia. by Wenbin Wu (292223)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1908
    Effects of lactoferrin and Coenzyme Q10 on skeletal muscle of mice.

    Effects of lactoferrin and Coenzyme Q10 on skeletal muscle of mice. by Wenbin Wu (292223)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1909
    Parameters for the treadmill during the testing phase.

    Parameters for the treadmill during the testing phase. by Wenbin Wu (292223)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1910
    Transcriptome sequencing enriched sarcopenia related GO Biological process (BP) and Molecular function (MF). Enriched GO BP of DEGs.

    Transcriptome sequencing enriched sarcopenia related GO Biological process (BP) and Molecular function (MF). Enriched GO BP of DEGs. by Wenbin Wu (292223)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1911
    HE staining of the gastrocnemius muscle.

    HE staining of the gastrocnemius muscle. by Wenbin Wu (292223)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1912
    qPCR verified the expression changes of GO and KEGG pathway enriched sarcopenia related DEGs.

    qPCR verified the expression changes of GO and KEGG pathway enriched sarcopenia related DEGs. by Wenbin Wu (292223)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1913
    FAT1 and MIB2 control tumor growth <i>in vivo.</i>

    FAT1 and MIB2 control tumor growth <i>in vivo.</i> by Rui Li (4631)

    Published 2025
    Save to List
    Saved in:
  14. 1914
    Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions.

    Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1915
    Health inequalities in the burden of IBD among WCBA.

    Health inequalities in the burden of IBD among WCBA. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1916
    Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040.

    Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1917
    The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021.

    The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1918
    Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040.

    Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1919
    The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021.

    The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1920
    Frontier analysis for the potential for improvement in reducing the burden of IBD among WCBA across 204 countries and regions.

    Frontier analysis for the potential for improvement in reducing the burden of IBD among WCBA across 204 countries and regions. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: